These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21916302)

  • 1. [Neoadjuvant radiochemotherapy for rectal cancer].
    Zehentmayr F; Wolf M; Weissenborn Y; Feldmann HJ; Belka C
    MMW Fortschr Med; 2011 Sep; 153(35):31-3. PubMed ID: 21916302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extended preoperative course of radiotherapy as component of combined and complex treatment of locally-advanced ampular rectal cancer].
    Semikopov KV; Vazhenin AV; Nadvikova EA; Lukina EIu
    Vopr Onkol; 2010; 56(1):70-2. PubMed ID: 20361620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectal carcinoma. Optimizing treatment by neoadjuvant and adjuvant therapy?].
    Fasolini F
    Zentralbl Chir; 1999; 124(5):441-5. PubMed ID: 10420532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute proctocolitis with commencement of neoadjuvant chemoradiation for rectal cancer.
    Kendal WS; Jonker D; Stern H; Moyana T
    Am J Clin Oncol; 2006 Oct; 29(5):534-5. PubMed ID: 17023795
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.
    Czito BG; Willett CG
    Semin Radiat Oncol; 2011 Jul; 21(3):203-11. PubMed ID: 21645865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
    Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
    Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multidisciplinary management of rectal cancer.
    Meredith KL; Hoffe SE; Shibata D
    Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
    Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.
    Kalady MF; de Campos-Lobato LF; Stocchi L; Geisler DP; Dietz D; Lavery IC; Fazio VW
    Ann Surg; 2009 Oct; 250(4):582-9. PubMed ID: 19710605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal cancer adjuvant chemotherapy: when is more useful?
    Pasetto LM; Basso U; Sinigaglia G; Pucciarelli S; Friso ML; Rugge M; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(3B):1805-12. PubMed ID: 18630464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Choice of treatment in rectal cancer. Consensus Conference, Chamber of Commerce and Industry, Paris, December 1-2, 1994].
    Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):226-30, 233-6. PubMed ID: 7486820
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rectal cancer: treatment and results].
    Luna Pérez P
    Rev Invest Clin; 2001; 53(1):65-76. PubMed ID: 11332053
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
    Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
    Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?
    Glynne-Jones R; Anyamene N
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):319-20. PubMed ID: 16965984
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant combined radiochemotherapy of rectum carcinoma with long-term 5-fluorouracil infusion].
    Fischbach W
    Z Gastroenterol; 1997 Mar; 35(3):227-8. PubMed ID: 9173691
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].
    Moosmann N; Boeck S; Heinemann V
    Med Klin (Munich); 2007 Jul; 102(7):551-62; quiz 563-4. PubMed ID: 17634873
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant therapy of rectal cancer].
    Bouaouina N; Boussen H
    Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant and adjuvant radiochemotherapy for rectal carcinoma].
    Seegenschmiedt MH
    MMW Fortschr Med; 2007 Jun; 149(23):33-5. PubMed ID: 18062575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for colon and rectal cancer.
    Ratkin GA
    Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.